Zealand phase 2 data on petrelintide shows durable weight loss (ZLDPF:OTCMKTS)
· seekingalpha.com
Phase 2 data show Zealand Pharma’s petrelintide drove up to 10.7% weight loss at 42 weeks. Read more here.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...